2 recruiting, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Unknown 1 |
Follow Huons Biopharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate HU-045 With Moderate to Severe Glabellar Lines HU-045, Xeomin® - Glabellar Lines | Phase 3 | Recruiting | Huons Biopharma | 390 | 2026-09-03 | 2026-10-13 |
| To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III) HU-045, Xeomin® - Glabellar Lines | Phase 3 | Recruiting | Huons Biopharma | 312 | 2024-06-20 | 2024-10-03 |
| To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy Botulinum toxin type A, normal Saline - Benign Masseteric Hypertrophy | Phase 3 | Unknown | Huons Biopharma | 188 | 2023-07-25 | 2024-09-26 |
incobotulinumtoxinA (2) · Botulinum Toxins, Type A (1) · Saline Solution (1)
South Korea (3)